Results 81 to 90 of about 309 (92)

Itraconazole-Associated Fixed Drug Eruption in a Patient With Allergic Bronchopulmonary Aspergillosis: A Case Report and Review of the Literature. [PDF]

Cureus
Thomas RS, Joseph G, Bhatti N, Badyal DK.   +3 more
europepmc   +1 more source

Editorial: Exploring cutaneous drug-related and drug-associated adverse events: from clinical insight to therapeutic management. [PDF]

Front Med (Lausanne)
Romagnuolo M, Crovella S, Abou-Saleh H, Moltrasio C.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adverse events following the use of immune checkpoint inhibitors: An analysis of the WHO VigiAccess database.

Journal of Clinical Oncology, 2019
e13118 Background: Immune checkpoint inhibitors (ICIs), especially ipilimumab (ipi) and nivolumab (nivo), have received approvals from the U.S. Food and Drug Administration for the treatment of multiple tumor types. These medications have shown great promise in the treatment of several malignancies but are associated with immune-related adverse ...
Nikita Nikita, Ralph Zinner, Jennifer Maria Johnson, Natasha Ghosh, Melissa Wilson, Grace L. Lu-Yao   +5 more
openaire   +1 more source

Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases

Expert Opinion on Drug Safety
The study endeavors to elucidate AE signals associated with zanubrutinib data from the WHO-VigiAccess and FAERS databases. The aim is to furnish robust scientific evidence to inform clinical practice and regulatory decisions.We meticulously extracted all AE breports tied to zanubrutinib from the both databases, encompassing the period from the drug's ...
Qiaofang, Liang, Xiaolin, Liao, Yushen, Huang, Jiang, Zeng, Cong, Liang, Ying, He, Hongwen, Wu   +6 more
exaly   +3 more sources

Descriptive Analysis of Adverse Drug Events of Three mTOR Inhibitors Using WHO-VigiAccess

Current Drug Safety
Introduction: The mechanistic target of rapamycin (mTOR) pathway regulates cell growth, metabolism, and survival. Its dysregulation contributes to cancer, autoimmune disorders, neurodegeneration, and aging. While mTOR inhibitors such as Sirolimus, Everolimus, and Temsirolimus are therapeutically valuable, they ...
Prerna Bhati, Prakash Haloi, Havagiray R. Chitme   +2 more
openaire   +1 more source

Characterization of Adverse Drug Effects to Three Radiopharmaceuticals: A Descriptive Analysis from WHO-VigiAccess

Cancer Biotherapy and Radiopharmaceuticals
Background: Radiopharmaceuticals are being used more frequently to treat neuroendocrine tumors and advanced prostate cancer; however, their clinical application is associated with adverse drug reactions (ADRs) that may affect patient safety.
Yiheng Jin, Kunlun Gui, Kaixin Chen, Xiaowu Wang, Xinlong Wan, Shugen Qu   +5 more
openaire   +1 more source

Class-level differences and within-class heterogeneity in heart failure reporting with immune checkpoint inhibitors: a WHO vigiaccess pharmacovigilance study

European Journal of Heart Failure
Abstract Background/Introduction Immune checkpoint inhibitors (ICIs) have revolutionised cancer care, but immune-related cardiotoxicity remains poorly catalogued beyond fulminant myocarditis. Emerging case series describe a clinically silent, acute left ventricular decompensation phenotype that
Y Shhab, B Yilmaz, A Nana, I E Tarabasanu-Mihaila, Z A Stepanov, A Qsous, R Alhaddadin   +6 more
openaire   +1 more source

Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess

Human Vaccines and Immunotherapeutics, 2022
Joseph Attakorah, Peter Yamoah, Neelaveni Padayachee   +2 more
exaly  

Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database

Pharmacological Research, 2017
Maria Del Zompo, Claudia Pisanu, Alberto Bocchetta   +2 more
exaly  

EPH74 COMPARATIVE POST-MARKETING SAFETY STUDY OF NIRSEVIMAB AND PALIVIZUMAB: A PHARMACOVIGILANCE ANALYSIS USING FAERS AND WHO VIGIACCESS

Value in Health
nipa chowdhury, Mohammad Al-Mamun
openaire   +1 more source